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 US MLE TEST 
A 76-year-old male with a 5 year history of atrial fibrillation 
presents to the Emergency Department with an inability to 
move his left leg. The patient notes that he first noted that his 
leg "felt funny" about two hours ago, and that it appeared to be 
more pale than normal. Since the leg started feeling funny, his 
ability to move it has decreased, to the point where he can no 
longer move it. He recently ran out of his warfarin, and hasn't 
taken any in two weeks. On physical exam his vital signs are 
within normal limits. His neurological exam reveals a pale, 
painful left leg with absent femoral and dorsalis pedis pulses. He 
has no other strength deficits and pulses in his right leg and 
right arm are intact. Which of the following would be the 
appropriate first action for this patient's condition?  
1.  Thrombolysis, 2.  Embolectomy, 3.  Fasciotomy, 
4.  Amputation, 5.  No intervention necessary   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient has an embolic occlusion of his 
left common iliac artery resulting in the pale, painful leg. The 
appropriate intervention would be an embolectomy to try 
and remove the occlusion. 
Incorrect Answers: 
1: Thrombolysis would be appropriate for a patient with an 
ischemic stroke., 3. A fasciotomy might be indicated after this 
patient's embolectomy, but would not be the initial 
management for this patient., 4: An amputation would be 
premature but may be indicated if the patient developed an 
infected limb., 5: This patient has an intervenable condition; 
thus, an embolectomy would be indicate. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Definition  
Heart arrhythmias (heart rhythm disturbances, cardiac 
arrhythmia, cardiac dysrhythmia, irregular heartbeat) is a 
group of conditions with abnormal variation from the normal 
heartbeat (irregular, too fast, or too slow) via congenital  (e.g., 
accessory atrioventricular connection, hereditary ion 
channelopathies) or acquired abnormalities of structure or 
function of heart and its conduction system or/and systemic 
abnormalities (electrolyte deviations, hypoxia, neuro and/or 
humoral (e.g. hormonal) imbalances (hypothyroidism, 
hyperthyroidism), chronic distress), and drugs and toxins 
(e.g., alcohol, caffeine). 
en.wikipedia.org/wiki/Cardiac_arrhythmia merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
Epidemiology   
  
eurheartj.oxfordjournals.org/content/early/2016/06/08/eurheartj.ehw128 myvmc.com/diseases/arrhythmia/ nhs.uk/conditions/arrhythmia/pages/arrhythmia.aspx 
• Heart arrhythmias are relatively common, often repetitive, 
occasionally persistent, and rarely life threatening .  
• The precipitants of heart arrhythmias vary with age (most 
serious arrhythmias affect people older than 60), gender, 
and associated comorbidity.  
• While heart arrhythmias are a frequent cause of 
emergency room  and primary care physician visits, they 
are infrequently the primary reason for hospital admission. 
• A recent study has suggested that 1 in 4 adult Americans 
over the age of 40 could develop an irregular heartbeat. 
• Certain types of heart arrhythmias can cause sudden 
cardiac death (100,000 people in the UK every year).  
 
Epidemiology 
(Total Hospitalization Days)    
http://198.173.66.121/myweb2/who_gets_a__fib.htm 
AF – atrial fibrillation, VF – ventricular fibrillation,  
VT – ventricular tachycardia 
Epidemiology 
(Worldwide Distribution of Atrial Fibrillation)    
circ.ahajournals.org/content/circulationaha/129/8/837/F7.large.jpg 
Epidemiology 
(Sudden Cardiac Arrest)    
http://www.sca-aware.org/about-sca 
Sudden cardiac arrest (SCA) is a leading cause of death among 
adults over the age of 40 in the United States and other 
countries.  
Epidemiology 
(Sudden Cardiac Death, per 1,000 person years)    
https://heartcurrents.files.wordpress.com/2010/02/wp_heart_cardiac_arrest.jpg 
Risk Factors and Etiology     
  
• Alcohol abuse 
• Diabetes 
• Drug abuse 
• Excessive coffee consumption 
• Heart disease 
• Hypertension   
• Hyperthyroidism (an 
overactive thyroid gland) 
 
• Mental stress 
• Scarring of the heart, often 
the result of a heart attack 
• Smoking 
• Some dietary supplements 
• Some herbal treatments 
• Some medications 
• Etc. 
emedicine.medscape.com/article/163062-overview#a4 
Risk Factors and Etiology 
(pathogenetic approach 1)   
  • Functional violations (physical and emotional stress, fever 
heat, increased intracranial pressure, respiratory 
disturbances, etc.). 
• Changed structure of the heart (coronary artery disease, 
cardiomyopathy,  valvular heart diseases, myocarditis, 
conductive tissue disease, etc.). 
• Systemic diseases (diabetes, lupus erythematosus, etc.). 
• Toxic injuries of the myocardium (alcohol, caffeine, 
tobacco, drugs,  some medications (adrenalin, 
noradrenalin, glucocorticoids, etc.), bacterial toxins, 
phosphor organic substances, etc.).  
my.clevelandclinic.org/services/heart/disorders/arrhythmia 
Risk Factors and Etiology 
(pathogenetic approach 2)   
  
• Nervous system disorder. 
• Hormone balance disorder (hyperthyroidism, 
hypothyroidism, etc.). 
• Violation of intracellular or extracellular ions balance 
(sodium, potassium, calcium, magnesium and chlorine). 
• Direct mechanical influences on the heart (catheter 
intervention, surgery, chest trauma). 
my.clevelandclinic.org/services/heart/disorders/arrhythmia 
 US MLE TEST 
A 59-year-old woman presents to the ED with 
palpitations, which she has never experienced before 
now. Her past medical history is notable for chronic 
obstructive pulmonary disease (COPD) for which she has 
been hospitalized once in the last year. On exam her T 
98.4F, HR 86, BP 105/70, RR 18, SpO2 94% on room air 
consistent with her baseline. Her EKG is shown in Figure 
A. What is the most common site of origin for ectopic foci 
causing the arrhythmia in this patient?  
1.  Tricuspid valve, 2.  Bicuspid valve  
3.  Pulmonary veins, 4.  Right ventricle, 5.  Left ventricle  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 3:  This patient has new onset atrial fibrillation; 
in atrial fibrillation the most likely site of origin for ectopic foci 
is the pulmonary veins. 
Incorrect Answers: 
1 and 2: Although left and right atrium ectopic foci can cause 
atrial fibrillation, ectopic foci in the pulmonary veins are the 
most common. Of note, the tricuspid annulus is the most 
common site for atrial flutter. 
4 and 5: Atrial fibrillation is a supraventricular tachycardia and 
by definition cannot originate in the ventricle.  
 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Mechanisms 1     
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
• There are four basic mechanisms— conduction violations, 
enhanced or suppressed automaticity, triggered activity, or 
re-entry.  
• Conduction violation can result in sinus, atrium, atrium-
ventricular and ventricle block; and in pre-excitations 
(Wolf-Parkinson-White) syndrome. 
• Suppression of automaticity of the sinoatrial (SA) node can 
result in sinus node dysfunction, and sick sinus syndrome 
(SSS), which is still the most common indication for 
permanent pacemaker implantation  
• Enhanced automaticity can result in multiple arrhythmias, 
both atrial and ventricular.   
Mechanisms 2     
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
• Triggered activity occurs when early afterdepolarizations 
and delayed afterdepolarizations initiate spontaneous 
multiple depolarizations, precipitating ventricular 
arrhythmias.  
• The most common mechanism of arrhythmogenesis results 
from reentry (micro- and macro-); requisites for reentry 
include bidirectional conduction and unidirectional block.    
Mechanisms 3    
am-medicine.com/2013/11/harrisons-internal-medicine-pdf.html 
Bradyarrhythmias typically arise from disturbances in impulse 
formation at the level of the sinoatrial node (SA) or from 
disturbances in impulse propagation at any level, including 
exit block from the SA, conduction block in the 
atrioventricular node (AVN) and impaired conduction in the 
His-Purkinje system.  
Mechanisms 4    
am-medicine.com/2013/11/harrisons-internal-medicine-pdf.html 
Tachyarrhythmias can be classified according to mechanism, 
including enhanced automaticity (spontaneous depolarization 
of atrial, junctional, or ventricular pacemakers), triggered 
arrhythmias (initiated by afterdepolarizations occurring 
during or immediately after cardiac repolarization,  during 
phase 3 or 4 of the action potential), or reentry (circus 
propagation of a depolarizing  wavefront).   
Mechanisms 5  
https://en.wikipedia.org/wiki/Heart_block 
 Conduction Block: a block can be find in every part of the 
conduction system of the heart.   
Mechanisms  6 
 tmedweb.tulane.edu/pharmwiki/doku.php/cellular_basis_for_arrhythmias 
Enhanced Automaticity: lowered action potential makes SA 
node more irritable; makes arrhythmias more likely - 
Increased intracellular calcium causes earlier phase 4 
upstroke. 
Mechanisms 7 
fce-study.netdna-ssl.com/images/upload-flashcards/back/3/4/50043556_m.jpg 
Suppressed Automaticity: lowered action potential due to 
digoxin makes sinoatrial node (SA node) more irritable; makes 
arrhythmias more likely - Increased intracellular calcium 
causes earlier phase 4 upstroke. 
Mechanisms 8  
humanphysiology.academy/D.CVS/D.6.CVSPathophysiologie/D.5.3.ArrhythmiaA.html 
Early After Depolarization: Sometimes, during 
the plateau phase of the action potential, a 
spontaneous depolarization may occur. This is 
often the case when there is too much calcium 
in the cell. These depolarizations may reach 
threshold and induce, too soon, a new action 
potential. 
Delayed After Depolarization: This is similar to 
the early after depolarizations but these occur 
after full repolarization has taken place, hence 
their name, delayed (or late) after 
depolarizations. 
Triggered Activity 
Mechanisms 9   
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
Reentry 1: Atrioventricular nodal reentry is used as an 
example. Two pathways connect the same points. Pathway A 
has slower conduction and a shorter refractory period. 
Pathway B conducts normally and has a longer refractory 
period. 
Mechanisms 10   
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
Reentry 2  
I. A normal impulse arriving at 1 
goes down both A and B pathways. 
Conduction through pathway A is 
slower and finds tissue at 2 already 
depolarized and thus refractory. A 
normal sinus beat results.  
Mechanisms 11    
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
Reentry 3 
II. A premature impulse finds pathway B 
refractory and is blocked, but it can be 
conducted on pathway A because its 
refractory period is shorter. On arriving at 2, 
the impulse continues forward and 
retrograde up pathway B, where it is blocked 
by refractory tissue at 3. A premature 
supraventricular beat with an increased PR 
interval results. 
Mechanisms 12    
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
Reentry 4 
 III. If conduction over pathway A is 
sufficiently slow, a premature impulse 
may continue retrograde all the way up 
pathway B, which is now past its 
refractory period. If pathway A is also 
past its refractory period, the impulse 
may reenter pathway A and continue to 
circle, sending an impulse each cycle to 
the ventricle (4) and retrograde to the 
atrium (5), producing a sustained 
reentrant tachycardia. 
 US MLE TEST 
A 35-year-old male presents to the emergency room with 
shortness of breath dizziness, and the complaint that he 
cannot stop his heart from pounding. He has no other 
medical problems and denies the use of alcohol, tobacco, 
and drugs. He is afebrile, with a blood pressure of 110/70 
mmHg, pulse of 214/min, and respiration rate of 22/min. 
Figure A is an electrocardiogram (EKG) strip from lead II. 
The patient suffers from which of the following 
arrhythmias?  
1.  Multifocal atrial tachycardia, 2.  Paroxysmal 
supraventricular tachycardia, 3.  Atrial fibrillation with 
rapid ventricular response  
4.  Atrial bigeminy, 5.  Sinus tachycardia  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  The patient’s EKG demonstrates a regular 
rhythm with narrow QRS complexes and absent P waves. Such 
findings suggest paroxysmal supraventricular tachycardia (SVT). 
Incorrect Answers: 
1: Multifocal atrial tachycardia is common in patients with COPD. It 
is an irregular rhythm with P waves of various morphologies., 3: A 
lack of distinct P waves marks atrial fibrillation with rapid 
ventricular response. R-R intervals typically vary and QRS 
complexes may be widened., 4: In atrial bigeminy, a premature 
atrial beat is repeatedly coupled to the end of a normal cycle. 
Atrial bigeminy is not a tachyarrhythmia., 5: In sinus tachycardia 
each QRS complex is preceded by a P wave.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Mechanisms 13  
(Atrial Fibrillation) 
http://content.onlinejacc.org/article.aspx?articleid=1854230 
Classification 
(International Classification of Diseases (ICD): 1) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
Chapter IX 
I30-I52 Other forms of heart disease   
 I44 Atrioventricular and left bundle-branch block (I44.0 Atrioventricular 
block, first degree; I44.1 Atrioventricular block, second degree: type I and II; I44.2 
Atrioventricular block, complete;  I44.3 Other and unspecified atrioventricular block; 
I44.4 Left anterior fascicular block; I44.5 Left posterior fascicular block; I44.6 Other 
and unspecified fascicular block ; I44.7 Left bundle-branch block, unspecified). 
 I45 Other conduction disorders (I45.0 Right fascicular block; I45.1 Other and 
unspecified right bundle-branch block; I45.2 Bifascicular block; I45.3 Trifascicular 
block; I45.4 Nonspecific intraventricular block;  I45.5 Other specified heart block;  
I45.6 Pre-excitation syndrome (Lown-Ganong-Levine syndrome, Wolff-Parkinson-
White syndrome);  I45.8 Other specified conduction disorders: atrioventricular [AV] 
dissociation  (R94.3); I45.9 Conduction disorder, unspecified).  
 146 Cardiac arrest (I46.0 Cardiac arrest with successful resuscitation;  
I46.1 Sudden cardiac death; I46.9 Cardiac arrest, unspecified). 
 
 
Classification 
(International Classification of Diseases (ICD): 2) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
Chapter IX 
I30-I52 Other forms of heart disease   
 147 Paroxysmal tachycardia ( I47.0 Re-entry ventricular arrhythmia; I47.1 
Supraventricular tachycardia; I47.2 Ventricular tachycardia, I47.9 Paroxysmal 
tachycardia, unspecified). 
 I48 Atrial fibrillation and flutter (I48.0 Paroxysmal atrial fibrillation, 
I48.1Persistent atrial fibrillation, I48.2 Chronic atrial fibrillation, I48.3Typical atrial 
flutter, Type I atrial flutter, I48.4 Atypical atrial flutter, Type II atrial flutter, I48.9Atrial 
fibrillation and atrial flutter, unspecified). 
 I49 Other cardiac arrhythmias (I49.0 Ventricular fibrillation and flutter, I49.1 
Atrial premature beats, I49.2 Junctional premature beats, I49.3 Ventricular premature 
beats , I49.4 Other and unspecified premature beats, I49.5 Sick sinus syndrome, I49.8 
Other specified cardiac arrhythmias (Brugada syndrome, Long QT syndrome, Rhythm 
disorder: coronary sinus, ectopic, nodal), I49.9 Cardiac arrhythmia, unspecified.  
Classification 
(International Classification of Diseases (ICD): 3) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
Chapter IX 
 R00 Abnormalities of heart beat. 
          R00.0 Tachycardia, unspecified. 
         R00.1 Bradycardia, unspecified: 
     Bradycardia: sinoatrial 
              sinus 
              vagal 
              Slow heart beat (use additional external cause code (Chapter XX), 
if desired, to identify drug, if drug-induced). 
         R00.2 Palpitations 
     Awareness of heart beat 
         R00.8 Other and unspecified abnormalities of heart beat 
Classification 
(Types of Arrhythmia) 
icd10coded.com/cm/ch9/I20-I25/ 
• Conduction violations: 
• Block (sinus one, atrium one, atrium-ventricular one, 
ventricle one).  
• Wolf-Parkinson-White syndrome (pre-excitations syndrome). 
• Automatism violations: 
• homotopic automatism violation (sinus tachycardia, sinus 
bradycardia, sinus arrhythmia) 
• heterotopic automatism violation (atrium-ventricular rhythm, 
idioventricular rhythm). 
• Combined heart rhythm violations (extrasystole, paroxysmal 
tachycardia, atrial flutter, ventricle flutter, atria fibrillation, 
ventricle fibrillation). 
Classification 
(Heart Blocks) 
https://en.wikipedia.org/wiki/Heart_block 
Location Name 
Within the sinoatrial node (SA 
node or Sinus node) 
Sinoatrial nodal blocks (SA nodal 
block, SA block, Sinoatrial block) 
Within the atrioventricular 
node (AV node) 
Atrioventricular block (AV nodal 
block, AV block or AVB) 
At and below the bundle of His 
Intra-Hisian blocks and Infra-Hisian 
blocks respectively 
Within the left or right bundle 
branches 
Bundle branch blocks  
Within the fascicles of the left 
bundle branch 
"Fascicular block" or Hemiblocks  
Classification 
(Heart Blocks Detalization) 
https://en.wikipedia.org/wiki/Heart_block 
• Sinoatrial (SA) nodal blocks:  SA node Wenckebach (Mobitz I), SA 
node Mobitz II, SA node exit block (in addition, the SA node can 
be suppressed by any other arrhythmia that reaches it 
(retrograde conduction from the ventricles, ectopic atrial beats, 
atrial fibrillation, and atrial flutter). 
• Atrioventricular  (AV) nodal blocks: first-degree AV block, 
second-degree AV block (type I or Mobitz I, also known as 
Wenckebach block; type 2 or Mobitz II), third-degree AV 
block (complete heart block). 
• Infra-Hisian block: type 2 second degree heart block or Mobitz II 
(left anterior fascicular block, left posterior fascicular block). 
• Right bundle branch block.  
 
Classification 
(Premature Contraction or Extrasystoles) 
http://www.fpnotebook.com/cv/ekg/PrmtrVntrclrCntrctn.htm 
Level: atrial, 
junctional, ventricular  
Frequency: rare, 
frequent,  
Focus: unifocal, 
multifocal  
Time of occurrence: 
early, late 
 
Regularity: regular (bigeminy 
(extrasystole follows every sinus 
beat), trigeminy (extrasystole 
follows every other sinus beat 
(every third beat is ectopic)), 
irregular  
: single beats, couplet beats, 
triplet beats, interpolated  
Classification 
(Lown Criteria of Premature Ventricular Contractions) 
medfac.wikifoundry.com/page/Lown's+Grading+of+PVCs 
Grade 0 No ventricular extrasystoles/ectopics 
Grade I Unifocal and infrequent PVCs; <30 PVCs per hour 
Grade II Unifocal and frequent PVCs, ≥30 PVCs per hour 
Grade III Multifocal 
Grade IVA 2 consecutive beats (couplets) 
Grade IVB ≥3 consecutive beats (salvos) 
Grade V "R on T" phenomenon 
>5 consecutive PVCs is considered a run of VT. This run of VT 
may either be sustained or non-sustained; treat as per VT. 
Classification 
(Atrial Fibrillation) 
http://emedicine.medscape.com/article/2500030-overview 
•  Paroxysmal atrial fibrillation (AF):  episodes of AF that 
terminate spontaneously or with intervention within 7 days. 
• Persistent AF:  episodes of continuous AF that last more than 7 
days and do not self-terminate. 
• Long-standing persistent AF:  episodes of continuous AF that 
last more than 12 months. 
• Permanent AF: Applies when a joint physician/patient decision 
has been made to accept the presence of AF and stop further 
attempts to restore and/or maintain sinus rhythm. 
• Nonvalvular AF:  AF in the absence of rheumatic mitral valve 
disease, a prosthetic heart valve, or mitral valve repair. 
Clinical Investigation  
(Signs and Symptoms) 
• Completely asymptomatic 
• Abnormal heartbeat 
(palpitations) 
• Forceful or painful extra beats 
• Shortness of breath 
• Temporarily absence of ability 
to breath 
• Chest discomfort or pain 
• Fluttering  
• Quivering  
• Hypotension 
• Diaphoresis 
 
 
• Neck fullness 
• Paleness 
• Vasovagal type response with 
light-headedness, dizziness, 
nausea, or loss of 
consciousness (vertigo, 
syncope, fainting)  
• Higher risk of blood clotting, 
embolization and stroke 
(atrial fibrillation) 
• Cardiac arrest, or sudden 
cardiac death 
 en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Diagnosis 
(Key Remarks) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
• Because there are a number of tests available for 
the diagnosis of cardiac arrhythmias, it is important 
to proceed with a stepwise approach.  
• The goal is to obtain a correlation between 
symptoms and the underlying arrhythmia and 
initiation of appropriate therapy.  
• Additional testing is usually advocated to identify 
patients with arrhythmias caused by ischemia or 
who are at risk for sudden cardiac death. 
 US MLE TEST 
A 58-year-old Caucasian male is being treated for atrial 
fibrillation and angina complains of dyspnea on exertion. 
On exam, his heart rate 104-115/min and irregularly 
irregular at rest. He has no chest pain. You believe his rate 
control for atrial fibrillation is suboptimal and the likely 
cause of his dyspnea. You are considering adding 
verapamil to his current metoprolol for additional rate 
control of his atrial fibrillation. Which of the following 
side effects should you be most concerned about with 
this additional medication?  
1.  Diarrhea, 2.  Shortening of action potential length at 
the AV node, 3.  Tachycardia, 4.  Hypotension, 5.  Torsades 
de pointes   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 4:  Verapamil is a calcium channel blocker 
used to treat hypertension, angina, and arrhythmia. When 
used with beta-blockers such as metoprolol, dangerous 
hypotension and bradycardia can result due to the additive 
negative chronotropic effects of the two drugs. 
Incorrect Answers: 
1: Verapamil causes constipation, not diarrhea., 2: Verapamil 
does not affect AP duration, as AP length is K+ dependent, 
not Ca2+ dependent., 3: Verapamil causes bradycardia, not 
tachycardia., 5: Verapamil can be used to treat or perhaps 
prevent Torsades de pointes in those at risk, it has not been 
implicated in causing it. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Diagnosis 
(Assessment of Structural Heart Disease) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
• Interviewing (complains, history) and physical examination with 
attention to coronary artery disease or myocardial infarctions, risk 
factors for coronary artery disease (CAD), and family history of 
sudden cardiac death are extremely important.  
• Auscultation may detect an irregular rhythm or premature beats.  
• Careful scrutiny of the electrocardiogram (ECG) is imperative to look 
for conduction system delays, QRS widening, previous myocardial 
infarction, or PVCs.  
• Stress testing, usually with imaging (e.g., stress echocardiography or 
stress thallium and echocardiography) can demonstrate the presence 
of CAD, LV dysfunction, or valvular heart disease. 
• Patients may present with a wide complex tachycardia, possibly VT 
versus SVT with aberrancy. The rule is that sustained or nonsustained 
wide complex tachycardia in patients with known CAD or previous 
myocardial infarction (MI) is VT until proven otherwise. 
Diagnosis 
(Holter Monitoring) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
Ambulatory 24- to 48-hour baseline Holter monitoring is 
useful in quantitating and qualifying arrhythmias in patients 
with frequent symptoms. Here intermittent  complete heart 
block in patient with syncope. HR – heart rate. 
Diagnosis 
(Event Recording) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ lumc.nl/pat/ima/80109063022221/1104210211343257.jpg  
thehearthealthcenter.com/wp/wp-content/uploads/2015/05/IMG_9920-09.jpg 
Event recording monitoring systems, or loop recorders can be 
worn for longer intervals (usually a month) and can document 
infrequent arrhythmia episodes and provide symptom-arrhythmia 
correlation.  
Diagnosis 
(Remote Magnetic Navigation) 
demanddeborah.org/wp-content/uploads/2014/10/Ischemic-VT-voltage-and-treatment-web.jpg 
dicardiology.com/product/stereotaxis-introduces-respiratory-compensation-remote-magnetic-navigation-procedures 
Diagnosis 
(Electrophysiologic Testing) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ lumc.nl/pat/ima/80109063022221/1104210211343257.jpg  
thehearthealthcenter.com/wp/wp-content/uploads/2015/05/IMG_9920-09.jpg 
Electrophysiologic testing is the gold standard for evaluating 
patients with recurrent syncope and can help identify underlying 
His-Purkinje disease, inducible VT, SVT, and sinus node 
dysfunction. Induced sustained monomorphic tachycardia. 
 
Diagnosis 
(Bradyarrhythmias 1) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• A regular QRS bradyarrhythmia with a 1:1 relationship 
between P waves and QRS complexes indicates absence of 
AV block;  P waves preceding QRS complexes indicate sinus 
bradycardia (if P waves are normal) or sinus arrest with an 
escape atrial bradycardia (if P waves are abnormal). 
• P waves after QRS complexes indicate sinus arrest with a 
junctional or ventricular escape rhythm and retrograde 
atrial activation.  
• An irregular QRS rhythm with a 1:1 relationship between P 
waves and the following QRS complexes indicates sinus 
arrhythmia with gradual acceleration and deceleration of 
the sinus rate (if P waves are normal).  
Diagnosis 
(Bradyarrhythmias 2) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• No relationship between P waves and QRS complexes 
indicates AV block; the escape rhythm can be junctional 
(narrow QRS complex) or ventricular (wide QRS complex). 
• Pauses in an otherwise regular QRS rhythm may be caused 
by blocked P waves (an abnormal P wave can usually be 
discerned just after the preceding T wave or distorting the 
morphology of the preceding T wave), sinus arrest, 
or sinus exit block, as well as by AV block. 
Diagnosis 
(SA blocks) 
  
https://en.wikipedia.org/wiki/Heart_block 
• SA blocks rarely give severe symptoms, because  the 
secondary pacemaker of the heart (AVN) is enough to 
retain consciousness in the resting state.   
• The SA can be suppressed by any other arrhythmia that 
reaches it (retrograde conduction from the ventricles, 
ectopic atrial beats, atrial fibrillation, and atrial flutter). 
• In SA block contrary to the SA suppression an electrical 
impulse is generated by the SA node that doesn't make the 
atria contract. 
Diagnosis 
(SA block) 
  
http://www.enurse-careplan.com/2012/01/ecg-sinoatrial-block.html 
Diagnosis 
(First-Degree AV Block) 
  
First-Degree degree AV block is defined as a prolonged interval between 
atrial and ventricular activation >200ms. This delay results from disease 
in the AV-node or His-Purkinje system. An AV block is not the cause of 
bradycardia, because every atrial impulse results in conduction to the 
ventricles.  
https://umem.org/files/uploads/content/ECG%20Challenge/Marked%201st%20degree%20AVB.jpg 
Diagnosis 
(Second-Degree AV Block) 
  
The presence of second-degree AV block is diagnosed when 
one or more (but not all) of the atrial impulses fail to conduct 
to the ventricles due to impaired conduction. 
https://en.wikipedia.org/wiki/Second-degree_atrioventricular_block 
Diagnosis 
(Third-Degree AV Block) 
  
Most patients are more symptomatic: syncope, near syncope, 
confusion (Adams Stokes attacks), dyspnea, severe angina, 
myocardial infarction, sudden death. 
http://www.fprmed.com/Pages/Cardio/3rdDegreeBlock.html 
Diagnosis 
(Infra-Hisian Block: Right Bundle Branch Block) 
  
https://en.wikipedia.org/wiki/Heart_block 
• Right bundle branch block (RBBB) can be found in healthy people and 
is represented by a broad QRS complex (>120ms). 
• A new RBBB in a patient with a history of normal ventricular 
conduction warrens further investigation. The last activity is to the 
right and results in a RSR’ pattern in V1 where R’ > R, , T-waves are 
usually inverted in V2 and V3, with some ST depression.. In V6 a 
slurred S wave can be seen at the end of the QRS complex. 
Diagnosis 
(Infra-Hisian Block: Left Anterior Fascicular Block) 
  
https://en.wikipedia.org/wiki/Heart_block 
• Left anterior fascicular block (LAFB) is composed of two fascicles.  
• One of the fascicle has an anterior location and activates the 
interventricular septum and the anterior of the ventricle.  
• Clinically a LAFB is represented by a left axis deviation and an absent 
or very small S and normal q in lead I and a S>R in lead II and III. QRS 
duration should be <120ms. 
Diagnosis 
(Infra-Hisian Block: Left Posterior Fascicular Block) 
  
https://en.wikipedia.org/wiki/Heart_block http://cdn.lifeinthefastlane.com/wp-content/uploads/2011/02/LAFB3.jpg 
• Left posterior fascicular block (LPFB) is composed of two fascicles, 
one of the fascicle has an anterior location and activates the 
interventricular septum and the anterior of the ventricle.  
• Clinically a LAFB is represented by a left axis deviation and an absent 
or very small S and normal q in lead I and a S>R in lead II and III. QRS 
duration should be <120ms. 
Diagnosis 
(Infra-Hisian Block: Left Bundle Branch Block) 
  
https://en.wikipedia.org/wiki/Heart_block http://cdn.lifeinthefastlane.com/wp-content/uploads/2011/02/LAFB3.jpg 
• Left bundle branch block (LBBB) is uncommon in healthy and need to 
be performed to screen for underlying disease.  
• LBBB results, most importantly a broad QRS of >120ms. In V1 a broad 
monomorphic S wave can be seen (sometimes with a small r wave) 
representing slow left ventricular activation. In the lead V6 a broad 
monomorphic R wave is seen with no Q wavesю 
Diagnosis 
(Infra-Hisian Block: Bifascicular Blocks) 
  
https://en.wikipedia.org/wiki/Heart_block http://ecg.utah.edu/lesson/6 
• RBBB plus either LAFB (common) or LPFB (uncommon) 
• Features of RBBB plus frontal plane features of the fascicular block 
(axis deviation, etc.) 
Diagnosis 
(Wolff-Parkinson-White Syndrome) 
  
https://en.wikipedia.org/wiki/Wolff%E2%80%93Parkinson%E2%80%93White_syndrome http://www.health-tutor.com/files/content/ECG/Wolff_Parkinson_White_syndrome_1_ecg.gif  
https://o.quizlet.com/ZUyDMrRqpBFkzx.L8-Lr4Q_m.png https://classconnection.s3.amazonaws.com/890/flashcards/648890/png/delta_wave1316004858636.png   
http://www.rcemlearning.co.uk/wp-content/uploads/SVT7-1.jpg 
Wolff–Parkinson–White syndrome (WPW) referred to as pre-excitation 
syndromes, and is caused by the presence of an abnormal accessory 
electrical conduction pathway between the atria and the ventricles. 
Electrical signals traveling down this abnormal pathway (known as the 
bundle of Kent) may stimulate the ventricles to contract prematurely, 
resulting in a unique type of supraventricular tachycardia referred to as 
an atrioventricular re-entrant tachycardia. 
Diagnosis 
(Tachyarrhythmias: Irregular, Narrow QRS Complex 1) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Irregular, narrow QRS complex tachyarrhythmias include 
atrial fibrillation (AF), atrial flutter or true atrial tachycardia 
with variable AV conduction, and multifocal atrial 
tachycardia.  
• Differentiation is based on atrial ECG signals, which are best 
seen in the longer pauses between QRS complexes.  
• Atrial ECG signals that are continuous, irregular in timing 
and morphology, and very rapid (> 300 beats/min) without 
discrete P waves indicate AF.   
Diagnosis 
(Tachyarrhythmias: Irregular, Narrow QRS Complex 2) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Discrete P waves that vary from beat to beat with at least 3 
different morphologies suggest multifocal atrial tachycardia.  
• Regular, discrete, uniform atrial signals without intervening 
isoelectric periods (usually at rates > 250 beats/min) 
suggest atrial flutter.  
• Regular, discrete, uniform, abnormal atrial signals with 
intervening isoelectric periods (usually at rates < 250 
beats/min) suggest true atrial tachycardia. 
Diagnosis 
(Tachyarrhythmias: Irregular, Wide QRS Complex) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Irregular, wide QRS complex tachyarrhythmias include the 
above 4 atrial tachyarrhythmias, conducted with either 
bundle branch block or ventricular preexcitation, and 
polymorphic ventricular tachycardia (VT).  
• Differentiation is based on atrial ECG signals and the 
presence in polymorphic VT of a very rapid rate (> 250 
beats/min). 
Diagnosis 
(Tachyarrhythmias: Regular, Narrow QRS Complex 1) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Regular, narrow QRS complex tachyarrhythmias include 
sinus tachycardia, atrial flutter or true atrial tachycardia 
with a consistent AV conduction ratio, and paroxysmal SVTs 
(AV nodal reentrant SVT, orthodromic reciprocating AV 
tachycardia in the presence of an accessory AV connection, 
and SA nodal reentrant SVT).  
• Vagal maneuvers or pharmacologic AV nodal blockade can 
help distinguish among these tachycardias.  
• With these maneuvers, sinus tachycardia is not terminated, 
but it slows or AV block develops, disclosing normal P 
waves.   
Diagnosis 
(Tachyarrhythmias: Regular, Narrow QRS Complex 2) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Similarly, atrial flutter and true atrial tachycardia are usually 
not terminated, but AV block discloses flutter waves or 
abnormal P waves.  
• The most common forms of paroxysmal SVT (AV nodal 
reentry and orthodromic reciprocating tachycardia) must 
terminate if AV block occurs. 
Diagnosis 
(Sinus Tachycardia) 
medicine.mcgill.ca/melp/tuts/rhythm/rhythm5.htm 
Rate around 108. Regular sinus rhythm - there is a P wave 
before each QRS and the P waves are up in II and down in 
aVR. 
Diagnosis 
(Atrial Tachycardia) 
clinicalgate.com/focal-atrial-tachycardia/ 
Surface ECG of multifocal atrial tachycardia. Note the varying 
morphology of the P waves and the PR intervals. 
Diagnosis 
(AV nodal reentrant SVT) 
ecgguru.com/ecg/dual-v-nodal-conduction 
Atrioventricular nodal reentrant tachycardia (AVNRT).  
Diagnosis 
(Tachyarrhythmias: Regular, Wide QRS Complex) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Regular, wide QRS complex tachyarrhythmias include those 
listed for a regular, narrow QRS complex tachyarrhythmia, 
each with bundle branch block or ventricular preexcitation, 
and monomorphic VT.  
• Vagal maneuvers can help distinguish among them.  
• ECG criteria to distinguish between VT and SVT with an 
intraventricular conduction defect are often used. 
• When in doubt, the rhythm is assumed to be VT because 
some drugs for SVTs can worsen the clinical state if the 
rhythm is VT; however, the reverse is not true. 
Diagnosis 
(Regular Wide QRS Complex Tachyarrhythmia) 
hqmeded-ecg.blogspot.com/2014/03/incessant-regular-wide-complex.html 
Regular monomorphic wide complex tachycardia with no P-
waves.   
Diagnosis 
(Narrow and Wide QRS Complexes) 
  
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhyt 
researchgate.net/figure/259650225_fig2_Figure-1-Left-panel-Relatively-narrow-QRS-complex-tachycardia-slightly-irregular-at2.bp.blogspot.c 
escardio.org/static_file/Escardio/Guidelines/publications/SVAguidelines-SVA-FT.pdf 
A narrow QRS complex (< 0.12 sec) 
indicates a supraventricular origin 
(above the His bundle bifurcation).  
A wide QRS complex (≥ 0.12 sec) 
indicates a ventricular origin (below 
the His bundle bifurcation) or a 
supraventricular rhythm conducted 
with an intraventricular conduction 
defect or with ventricular 
preexcitation in the Wolff-Parkinson-
White syndrome. 
Diagnosis 
(Brugada Criteria for Ventricular Tachycardia) 
  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
Diagnosis 
(Tachyarrhythmias: Regular, Wide QRS Complex) 
  
.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
• Regular, wide QRS complex tachyarrhythmias include those 
listed for a regular, narrow QRS complex tachyarrhythmia, 
each with bundle branch block or ventricular preexcitation, 
and monomorphic VT.  
• Vagal maneuvers can help distinguish among them.  
• ECG criteria to distinguish between VT and SVT with an 
intraventricular conduction defect are often used. 
• When in doubt, the rhythm is assumed to be VT because 
some drugs for SVTs can worsen the clinical state if the 
rhythm is VT; however, the reverse is not true. 
Diagnosis 
(Supraventricular Extrasystoles) 
http://www.health-tutor.com/supraventricular-extrasystoles-ecg.html http://www.n3wt.nildram.co.uk/ECG/ECG5.htm 
• Supraventricular extrasystoles originate in the atrial myocardium, or in 
the AV node and manifest as an early P wave, which has a 
morphology corresponding to the origin of the focus (negative if 
lower atrial focus, biphasic if left atrial, etc.).  
• The QRS complex can be normal or widened because of aberrancy.  
• Frequently, the conduction of the supraventricular extrasystoles is 
blocked, so that a pause occurs, which is further extended by the 
subsequent sinus pause.  
• They have no prognostic significance but can induce sustained 
arrhythmias. 
Diagnosis 
(Ventricular Extrasystoles) 
http://www.health-tutor.com/ventricular-extrasystoles-ecg.html http://www.n3wt.nildram.co.uk/ECG/ECG5.htm 
Ventricular extrasystoles can be differentiated from supraventricular 
extrasystoles by the following: 
• no preceding P wave (no constant PQ interval)  
• different QRS morphology, width, and axis  
• altered repolarization (T wave opposite to QRS vector) 
• compensatory pause.  
Single ventricular extrasystoles have no proven prognostic value, 
especially in the absence of structural heart disease.  
More than 3 consecutive ventricular extrasystoles are considered to be 
ventricular tachycardia, which represents a risk factor in patients with 
coronary heart disease or hypertrophic cardiomyopathy. 
Diagnosis 
(Combined Heart Rhythm Violations: Atrial Flutter ) 
 http://cdn.lifeinthefastlane.com/wp-content/uploads/2012/01/Flutter-4-1-block.jpg http://emedicine.medscape.com/article/151210-overview 
Atrial flutter is a cardiac arrhythmia characterized by atrial 
rates of 240-400 beats/min and some degree of AVN block.  
Diagnosis 
(Combined Heart Rhythm Violations: Atrial Fibrillation) 
https://en.wikipedia.org/wiki/Atrial_fibrillation#Pathophysiology 
In atrial fibrillation (AF), the normal 
regular electrical impulses 
generated by the sinoatrial node in 
the right atrium of the heart are 
overwhelmed by disorganized 
electrical impulses usually 
originating in the roots of 
the pulmonary veins with irregular 
conduction of ventricular impulses 
that generate the heartbeat. 
ECG of atrial fibrillation (top) 
and normal sinus rhythm 
(bottom). The purple arrow 
indicates a P wave, which is 
lost in atrial fibrillation. 
Treatment 
(General Principles 1) 
• Treatment of cause. 
• Asymptomatic arrhythmias without serious risks do not 
require treatment even if they worsen.  
• Reducing coffee, alcohol, or tobacco use or increasing the 
amount of rest may help to alleviate symptoms.  
• Symptomatic arrhythmias may require treatment to 
improve quality of life.  
• Potentially life-threatening arrhythmias require treatment. 
• The method of treatment depends firstly on whether or not 
the affected person is stable or unstable.   
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
Treatment 
(General Principles 2) 
• Treatments may include physical maneuvers, 
antiarrhythmic drugs, electricity conversion, catheter 
ablation, or electrosurgery. 
• Patients with arrhythmias that have caused or are likely to 
cause symptoms of hemodynamic compromise may have 
to be restricted from driving until response to treatment 
has been assessed.  
merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias 
en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
Treatment 
(Physical Maneuvers 1) 
• A number of physical acts can increase parasympathetic 
nervous supply to the heart, resulting in blocking of 
electrical conduction through the atrio-ventricular (AV) 
node.  
• Physical (vagal) maneuvers can slow down or stop a 
number of arrhythmias that originate above or at the AV. 
• The Valsalva maneuver should be the first vagal maneuver 
tried and works by increasing intra-thoracic pressure and 
affecting baroreceptors within the arch of the aorta. It is 
carried out by asking the patient to hold his/her breath 
while trying to exhale forcibly as if straining during a bowel 
movement.   
en.wikipedia.org/wiki/Cardiac_arrhythmia#Signs_and_symptoms en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
 
Treatment 
(Physical Maneuvers 2) 
• Other vagal maneuvers include holding one's breath for a 
few seconds, coughing, plunging the face into cold water, 
drinking a glass of ice cold water, etc. 
• Carotid sinus massage is effective but is often not 
recommended in the elderly due to the potential risk 
of stroke. 
en.wikipedia.org/wiki/Cardiac_arrhythmia#Signs_and_symptoms en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
 
Treatment 
(Vaughn-Williams Classification of Antiarrhythmic 
Medications) 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
Class Actions (Examples) 
I Sodium channel blockers 
IA Depress phase 0 of action potential; delay conduction, prolong repolarization—
phase III or IV (quinidine, procainamide, disopyramide) 
IB Little effect on phase 0 of action potential in normal tissues; depress phase 0 in 
abnormal tissues; shorten repolarization or little effect (lidocaine, tocainide, 
mexiletine, diphenylhydantoin) 
IC Depress phase 0 of action potential; markedly slow conduction in normal tissues 
(flecainide, propafenone, moricizine) 
II β-Adrenergic blocking agents (acebutolol, atenolol, bisoprolol, carvedilol, 
metoprolol, nadolol, pindolol, propranolol) 
III Prolong action potential duration by increasing repolarization and refractoriness 
(amiodarone, sotalol, bretylium, dofetilide, azimilide, ibutilide) 
IV Calcium channel blockers (diltiazem, verapamil) 
Others Digoxin, adenosine 
 US MLE TEST 
A 57-year-old Caucasian male presents to your office with 
heart palpitations and shortness of breath. On exam, he is 
tachycardic and his rhythm is irregularly irregular. He fails 
standard pharmacologic therapy and you refer to 
cardiology, where he is started on an antiarrhythmic 
medication. The action of this agent results in a longer 
action potential duration, an increased effective 
refractory period, and a longer QT interval. Which drug 
has been prescribed? 
1.  Flecanide, 2.  Propafenone, 3.  Mexiletine, 
4.  Diltiazem, 5.  Sotalol    
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 5:  All class III antiarrhythmics lengthen phase 
3 (the K+ efflux phase) of the ventricular action potential, 
resulting in a longer action potential duration, an increased 
effective refractory period, and a longer QT interval.  
Incorrect Answers: 
1 & 2: Flecanide and propafenone are class IC antiarrhythmics 
that block sodium channels; they do not increase the length 
of the action potential significantly., 3: Mexiletine is a class IB 
antiarrhythmic that blocks sodium channels and shortens the 
duration of the action potential., 4: Diltiazem is a class IV 
antiarrhythmic and decreases conduction through the AV 
node; it would have the above mentioned effects on the 
action potential. https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Treatment 
(Sinoatrial Block and Atrioventricular Block) 
• Sinoatrial blocks are typically well-tolerated and most often do 
not require treatment; emergency treatment, if deemed 
necessary, consists of administration of atropine sulfate or 
transcutaneous pacing. 
• First-degree AVN block and Mobitz I second-degree AVN block 
do not generally require treatment unless they cause symptoms 
and are not due to a reversible cause.  
• Mobitz II second-degree AVN block and third-degree AVN block 
usually require temporary and/or permanent cardiac pacing.  
• Pacemaker implantation is a routine surgical procedure, 
generally performed with conscious sedation and local 
anesthesia in the electrophysiology laboratory.  
http://emedicine.medscape.com/article/151597-treatment  https://en.wikipedia.org/wiki/Sinoatrial_block 
Treatment 
(Revolution in Implanted Pacemakers) 
    https://http://www.dailymail.co.uk/health/article-2692094/ME-AND-MY-OPERATION-The-tiny-pacemaker-thats-safer-doesnt-leave-scar.html 
://en.m.wikipedia.org/wiki/Artificial_cardiac_pacemaker#Biventricular_pacing 
Treatment 
(Supraventricular Tachycardia (SVT) 1) 
• Most SVTs are unpleasant rather than life-threatening, 
although very fast heart rates can be problematic for those 
with underlying ischemic heart disease or the elderly.  
• Episodes require treatment when they occur, but interval 
therapy may also be used to prevent or reduce recurrence.  
• SVTs can be classified by whether the AV node is involved in 
maintaining the rhythm: if so, slowing conduction through 
the AV node will terminate it; if not, AV nodal blocking 
maneuvers will not work, although transient AV block is still 
useful as it may unmask an underlying abnormal rhythm.  
en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
Treatment 
(Supraventricular Tachycardia (SVT) 2) 
• Adenosine, an ultra-short-acting AV nodal blocking agent, is 
indicated if vagal maneuvers are not effective; if 
unsuccessful or the permanent SVT (PSVT) 
recurs diltiazem or verapamil are recommended.[ 
• SVT that does not involve the AV node may respond to 
sotalol or amiodarone. 
• If the patient is hemodynamically unstable or other 
treatments have not been effective, synchronized electrical 
cardioversion may be used.   
 
en.wikipedia.org/wiki/Supraventricular_tachycardia#Physical_maneuvers 
Treatment 
(Regular Supraventricular Tachycardia of 
Uncertain Type) 
http://cardiology.jamanetwork.com/article.aspx?articleid=2527088 
Treatment 
(Ventricular tachycardia (VT): 1) 
• Patients suffering from pulseless VT or unstable VT are 
hemodynamically compromised and require immediate 
cardioversion. 
• If a person still has a pulse, it is usually possible to 
terminate the episode using cardioversion that should be 
synchronized to the heartbeat if the waveform is 
monomorphic if possible; an initial energy of 100J is 
recommended; if the waveform is polymorphic, then higher 
energies and an unsynchronized shock should be provided 
(also known as defibrillation).  
 en.wikipedia.org/wiki/Ventricular_tachycardia 
Treatment 
(Ventricular tachycardia (VT): 2) 
• For those who are stable with a monomorphic 
waveform the medications procainamide or sotalol may be 
used and are better than lidocaine; evidence does not 
show that amiodarone is better than procainamide. 
• As hypomagnesemia is a common cause of VT, magnesium 
sulphate can be given for torsades de pointes or if 
hypomagnesemia is found/suspected.  
• Long-term anti-arrhythmic therapy may be indicated to 
prevent recurrence of VT; beta-blockers and a number of 
class III antiarrhythmics are commonly used. 
 
  en.wikipedia.org/wiki/Ventricular_tachycardia 
Treatment 
(Cardioversion and Defibrillation) 
webmd.com/heart-disease/atrial-fibrillation/ss/slideshow-af-overview 
Treatment 
(Ventricular tachycardia (VT): 2) 
• Catheter ablation is a possible treatment for those with 
recurrent VT; remote magnetic navigation is one effective 
method to do the procedure.  
• An implantable cardioverter defibrillator  (ICVD) is more 
effective than drug therapy for prevention of sudden 
cardiac death due to VT and VF, but may be constrained by 
cost issues, as well as patient co-morbidities and patient 
preference. 
 en.wikipedia.org/wiki/Ventricular_tachycardia 
Treatment 
(Extrasystoles 1) 
• No heart disease (normal left ventricular function): 
• Avoid provocative factors. 
• Mild asymptomatic ventricular extrasystoles (PVCs) no 
management required. 
• Symptomatic PVCs accounting for <20% of total beats 
consider beta blocker for disabling symptoms. 
• PVCs account for >20% of total beats consider Cardiac 
Catheter Ablation.  
http://www.fpnotebook.com/cv/ekg/PrmtrVntrclrCntrctn.htm 
Treatment 
(Extrasystoles 2) 
• Heart disease (with left ventricular dysfunction) 
• PVCs increase risk of morbidity and mortality. 
• Consider management for Lown Class 3 
• Consider Cardiac Catheter Ablation. 
http://www.fpnotebook.com/cv/ekg/PrmtrVntrclrCntrctn.htm 
Treatment 
(Cardiac Catheter Ablation) 
dicardiology.com/sites/daic/files/styles/content_feed_large_new/public/field/image/EP%20Lab%20ablation%20procedure_From%20hospital%20PR.JPG?itok=-9U_XR1j 
Treatment 
(Implantable Cardioverter Defibrillator (ICVD)) 
dicardiology.com/article/advances-implantable-cardioverter-defibrillator-icd-technology 
Treatment 
(Atrial Fibrillation: Main Goals) 
• The main goals of treatment are to prevent circulatory 
instability and stroke.  
• Rate or rhythm control are used to achieve the former, 
whereas anticoagulation is used to decrease the risk of the 
latter. 
•  If cardiovascular system unstable due to 
uncontrolled tachycardia, immediate cardioversion is 
indicated.  
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
 US MLE TEST 
A 63-year-old man with a history of hypertension and 
atrial fibrillation is brought into the emergency room 
and found to have a ventricular tachyarrhythmia. 
Ibutilide is discontinued and the patient is switched to 
another drug that also prolongs the QT interval but is 
associated with a decreased risk of torsades de 
pointes. Which drug was most likely administered in 
this patient? 
1.  Sotalol, 2.  Digoxin, 3.  Esmolol, 4.  Amiodarone, 
5.  Quinidine   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 4:  Amiodarone is an antiarrhythmic that is 
unique in its ability to prolong the QT interval without 
predisposing the patient to torsades de pointes.  
Incorrect Answers: 
 1: Sotalol causes an increase in both the PR and QT interval. 
Its administration predisposes a patient to torsades de 
pointes., 2: Digoxin is a treatment for atrial fibrillation due to 
its depression of the SA node and it increases the length PR 
interval by prolonging conduction through the AV node., 3: 
Esmolol  prolongs the PR interval. It has no effect on the QT 
interval., 5: Quinidine increase the QT interval and predispose 
a patient to torsades de pointes. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Treatment 
(Atrial Fibrillation: Anticoagulants) 
• Anticoagulation reduce the risk of stroke and is 
recommended in most people other than those at low risk 
of stroke or those at high risk of bleeding. 
• The risk of stroke from non-valvular AF can be estimated 
using the CHA2DS2-VASc score, and anticoagulation is 
recommended if there is a score of 2 or more. 
• Anticoagulation can be achieved through a number of 
means including warfarin, heparin, dabigatran,rivaroxaban 
edoxaban, and apixaban.    
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Fibrillation: Anticoagulants) 
• Anticoagulation reduce the risk of stroke and is 
recommended in most people other than those at low risk 
of stroke or those at high risk of bleeding. 
• The risk of stroke from non-valvular AF can be estimated 
using the CHA2DS2-VASc score, and anticoagulation is 
recommended if there is a score of 2 or more. 
• Anticoagulation can be achieved through a number of 
means including warfarin, heparin, dabigatran,rivaroxaban 
edoxaban, and apixaban.    
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Fibrillation: CHA2DS2-VASc Score) 
http://blog.digitalneurosurgeon.com/wp-content/uploads/2012/02/CHA2DS2_VASc_score.png 
Treatment 
(Atrial Fibrillation: Therapeutic Window of Warfarin) 
http://www.revespcardiol.org/en/antiplatelet-and-anticoagulant-therapy-for/articulo/90002054/  http://blog.digitalneurosurgeon.com/wp-content/uploads/2012/02/CHA2DS2_VASc_score.png 
Treatment 
(Atrial Fibrillation: Rate Versus Rhythm Control) 
• Both methods have similar outcomes. 
• Rate control lowers the heart rate closer to normal, usually 
60 to 100 bpm, without trying to convert to a regular 
rhythm.  
• Rhythm control tries to restore a normal heart rhythm in a 
process called cardioversion and maintains the normal 
rhythm with medications.  
• Rhythm control is more important in the acute setting AF, 
whereas rate control is more important in the chronic 
phase.   
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Fibrillation: Strategies for Rhythm Control) 
http://content.onlinejacc.org/article.aspx?articleid=1854230  http://blog.digitalneurosurgeon.com/wp-content/uploads/2012/02/CHA2DS2_VASc_score.png 
Treatment 
(Atrial Fibrillation: Rate Control 1) 
• Rate control to a target heart rate of 110 bpm is 
recommended in most people. 
• Lower heart rates may be recommended in those with left 
ventricular hypertrophy or reduced left ventricular 
function. 
• Rate control can be done with: 
• Beta blockers (preferably the cardioselective beta blockers 
such as metoprolol, atenolol, bisoprolol,nebivolol). 
• Non-dihydropyridine calcium channel blockers 
(e.g., diltiazem or verapamil).  
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Fibrillation: Rate Control 2) 
• In those with chronic disease either beta blockers or 
calcium channel blockers are recommended. 
• Amiodarone can be used when other agents are 
contraindicated or ineffective (particularly due to 
hypotension).  
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Fibrillation: Cardioversion) 
• Electrical cardioversion involves the restoration of normal 
heart rhythm through the application of a DC electrical 
shock  
• Chemical cardioversion is performed with drugs, such as 
amiodarone, procainamide,dofetilide, ibutilide, propafenon
e, or flecainide. 
• After successful cardioversion the heart may be in a 
stunned state, which means that there is a normal rhythm 
but restoration of normal atrial contraction has not yet 
occurred.  
https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
 US MLE TEST 
A 21-year-old college female presents after her swim 
practice with persistent palpitations. The palpitations 
began 3 hours ago during a rigorous swim and are not 
accompanied by chest pain, shortness of breath, nausea 
or vomiting. The patient has a documented history of 
Wolff-Parkinson-White (WPW). She denies recent alcohol 
or drug use. On physical exam, the patient's blood 
pressure is 115/70. EKG shows atrial fibrillation with a 
rate of 170/min. What is the most appropriate next step 
in management? 
1.  Procainamide, 2.  Adenosine, 3.  Atenolol, 
4.  Diltiazem, 5.  Digoxin  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 1:  The correct answer is 
procainamide, since patients with atrial fibrillation 
secondary to WPW should not be treated with 
atrioventricular (AV) nodal blockers. 
Incorrect Answers: 
2-5: These drugs all block the AV node in some 
capacity and, therefore, are contraindicated in WPW. 
 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Treatment 
(Atrial Fibrillation: Interventional Procedures) 
• Surgery 
• Ablation 
• Left atrial appendage occlusion 
http://www.afibmatters.org/static_file/AFibMatters/Images/Left-atrial-appendage-closure.jpg  https://en.wikipedia.org/wiki/Atrial_fibrillation#Management 
Treatment 
(Atrial Flutter) 
• General treatment goals for symptomatic atrial flutter are 
similar to those for atrial fibrillation and include the 
following: 
• Control of the ventricular rate. 
• Restoration of sinus rhythm. 
• Prevention of recurrent episodes or reduction of their 
frequency or duration. 
• Prevention of thromboembolic complications. 
• Minimization of adverse effects from therapy. 
http://emedicine.medscape.com/article/151210-treatment 
Prognosis  
• The outlook for cardiac arrhythmias depends on the type of 
rhythm disturbance and whether the person has coronary 
artery disease, congestive heart failure, or some other 
heart muscle or other disorder.  
• The prognosis for ventricular fibrillation is grave, and death 
follows quickly without emergency treatment.  
• Most atrial arrhythmias have an excellent prognosis.  
• The availability of permanent pacemakers, implanted 
cardioversion/defibrillation devices and effective 
medications has improved the prognosis for many people 
with serious cardiac arrhythmias. 
www.sparkpeople.com/resource/health_a-z_detail.asp?AZ=81&Page=8 
Prophylaxis 
• Once an acute arrhythmia has been terminated, ongoing 
treatment may be indicated to prevent recurrence.   
• In general, patients with more frequent or disabling 
symptoms warrant some form of prevention.  
• A variety of drugs including simple AVN nodal blocking 
agents such as beta-blockers and verapamil, as well as 
antiarrhythmic may be used, usually with good effect, 
although the risks of these therapies need to be weighed 
against potential benefits. 
• Radiofrequency ablation has revolutionized the treatment 
of tachycardia caused by a reentry pathway.   
en.wikipedia.org/wiki/Supraventricular_tachycardia#Medications 
Abbreviations  
AF - atrial fibrillation  
AV - atrio-ventricular  
AVB - atrioventricular block  
AVNRT - atrioventricular nodal reentrant 
tachycardia  
AF - atrial fibrillation   
CAD - coronary artery disease  
ECG - electrocardiogram  
IHR – heart rate 
CD - International Classification of 
Diseases  
ICVD - Implantable Cardioverter 
Defibrillator 
LAFB - Left anterior fascicular block 
LBBB - left bundle branch block  
 
 
LPFB - left posterior fascicular block LV - left 
ventricle 
MDP - membrane diastolic potential 
MI - myocardial infarction 
PSVT -permanent SVT  
PVCs – premature ventricular contractions 
RAAS - renin–angiotensin–aldosterone 
system  
RBBB - Right bundle branch block SVT- 
supraventricular Tachycardia  
SA node –sinoatrial node 
Th - threshold  
VF – ventricular fibrillation 
VT – ventricular tachycardia 
WPW - Wolff–Parkinson–White syndrome  
Diagnostic and treatment guidelines 
• ACC/AHA/ESC Guidelines for the Management of Patients With 
Supraventricular Arrhythmias 
• ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac 
Rhythm Abnormalities 
• 2012 focused update of the ESC Guidelines for the management of 
atrial fibrillation 
• 2014 AHA/ACC/HRS Guideline for the Management of Patients With 
Atrial Fibrillation: Executive Summary 
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients 
With Supraventricular Tachycardia 
• 2015 ESC Guidelines for the management of patients with ventricular 
arrhythmias and the prevention of sudden cardiac death   
 
 
 
